| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
72,852 |
70,302 |
$9.81M |
| T1015 |
Clinic visit/encounter, all-inclusive |
117,147 |
92,226 |
$6.63M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
48,717 |
46,790 |
$4.31M |
| G0378 |
Hospital observation service, per hour |
3,844 |
3,572 |
$3.76M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
32,425 |
31,569 |
$3.12M |
| 90834 |
Psychotherapy, 45 minutes with patient |
37,963 |
22,028 |
$2.40M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,058 |
13,189 |
$2.36M |
| 87631 |
|
13,573 |
13,334 |
$1.96M |
| X0621 |
|
6,150 |
3,677 |
$1.38M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,920 |
7,227 |
$791K |
| 99215 |
Prolong outpt/office vis |
10,601 |
8,012 |
$715K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,622 |
6,579 |
$692K |
| J9271 |
Injection, pembrolizumab, 1 mg |
223 |
181 |
$631K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,045 |
3,920 |
$617K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,490 |
8,822 |
$539K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
18,108 |
16,373 |
$502K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
17,640 |
17,256 |
$502K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,406 |
4,373 |
$468K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
91,132 |
81,030 |
$466K |
| 80053 |
Comprehensive metabolic panel |
43,689 |
39,115 |
$457K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
7,088 |
6,723 |
$323K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15,560 |
15,200 |
$313K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,183 |
2,154 |
$309K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,537 |
10,059 |
$305K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,296 |
16,477 |
$304K |
| 71046 |
Radiologic examination, chest; 2 views |
19,926 |
19,151 |
$303K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
33,040 |
29,657 |
$297K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,305 |
2,653 |
$277K |
| 87536 |
|
2,465 |
2,423 |
$276K |
| G9012 |
Other specified case management service not elsewhere classified |
1,200 |
1,171 |
$262K |
| 87481 |
|
3,853 |
2,639 |
$260K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,380 |
4,191 |
$259K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,132 |
6,082 |
$259K |
| 80050 |
General health panel |
4,891 |
4,745 |
$247K |
| 95811 |
|
477 |
449 |
$244K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,361 |
2,325 |
$243K |
| 90832 |
Psychotherapy, 30 minutes with patient |
6,346 |
4,630 |
$230K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
828 |
796 |
$230K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,650 |
6,237 |
$227K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
24,296 |
22,121 |
$211K |
| 80061 |
Lipid panel |
14,322 |
13,897 |
$203K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,136 |
1,091 |
$198K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,780 |
4,689 |
$179K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,023 |
2,772 |
$176K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
21,317 |
20,133 |
$172K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,654 |
1,632 |
$167K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,863 |
1,825 |
$163K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,673 |
7,365 |
$161K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,835 |
3,775 |
$155K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,081 |
3,613 |
$151K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
681 |
637 |
$138K |
| 86360 |
|
2,173 |
2,136 |
$137K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,630 |
9,101 |
$133K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,659 |
4,554 |
$132K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,860 |
6,218 |
$132K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
432 |
422 |
$131K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
576 |
565 |
$127K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
3,928 |
3,846 |
$127K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
439 |
439 |
$120K |
| 84484 |
|
15,742 |
13,471 |
$119K |
| 86780 |
|
7,471 |
7,287 |
$119K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,671 |
1,627 |
$114K |
| 93975 |
|
977 |
934 |
$110K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
2,979 |
1,232 |
$109K |
| 62323 |
|
344 |
339 |
$107K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,822 |
1,613 |
$107K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
4,927 |
4,827 |
$106K |
| 86359 |
|
2,174 |
2,138 |
$103K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
128 |
126 |
$101K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,344 |
5,269 |
$99K |
| G0008 |
Administration of influenza virus vaccine |
12,549 |
12,323 |
$97K |
| 87480 |
|
3,945 |
3,816 |
$96K |
| 76830 |
Ultrasound, transvaginal |
2,020 |
1,961 |
$96K |
| 36415 |
Collection of venous blood by venipuncture |
17,558 |
15,285 |
$92K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
501 |
488 |
$91K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,438 |
6,296 |
$90K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,130 |
1,086 |
$90K |
| 82248 |
|
15,443 |
14,534 |
$89K |
| 84702 |
|
5,021 |
4,176 |
$86K |
| 83735 |
|
15,978 |
13,541 |
$86K |
| 87660 |
|
3,565 |
3,458 |
$85K |
| 81003 |
|
26,588 |
22,354 |
$85K |
| J1750 |
Injection, iron dextran, 50 mg |
3,634 |
2,326 |
$82K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
91 |
57 |
$81K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,405 |
1,341 |
$80K |
| 82728 |
|
6,791 |
6,510 |
$79K |
| 81001 |
|
26,691 |
25,190 |
$78K |
| 83970 |
|
1,754 |
1,722 |
$76K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,446 |
1,429 |
$74K |
| 86803 |
|
3,706 |
3,603 |
$72K |
| 87150 |
|
1,557 |
1,523 |
$70K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,110 |
1,082 |
$69K |
| T1001 |
Nursing assessment / evaluation |
1,002 |
995 |
$69K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,172 |
9,904 |
$67K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,463 |
3,244 |
$65K |
| 99188 |
|
3,336 |
3,318 |
$65K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
1,273 |
989 |
$64K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
307 |
301 |
$64K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,159 |
1,131 |
$63K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
22,397 |
19,067 |
$62K |
| 87510 |
|
3,633 |
3,518 |
$62K |
| 77066 |
Tomosynthesis, mammo |
706 |
690 |
$62K |
| 81513 |
|
947 |
942 |
$60K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
390 |
380 |
$57K |
| 93971 |
|
948 |
871 |
$54K |
| 82607 |
|
4,372 |
4,292 |
$54K |
| H0039 |
Assertive community treatment, face-to-face, per 15 minutes |
514 |
128 |
$53K |
| 81025 |
|
13,323 |
12,787 |
$51K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,443 |
1,413 |
$51K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
87 |
63 |
$51K |
| 76642 |
|
1,229 |
1,191 |
$51K |
| 97162 |
|
1,156 |
1,120 |
$49K |
| G0009 |
Administration of pneumococcal vaccine |
6,279 |
6,145 |
$48K |
| 85610 |
|
15,016 |
13,459 |
$47K |
| 83880 |
|
1,730 |
1,599 |
$46K |
| 74183 |
|
128 |
126 |
$46K |
| 99429 |
|
228 |
228 |
$46K |
| 90651 |
|
978 |
958 |
$45K |
| 88342 |
|
1,082 |
1,038 |
$44K |
| 92551 |
|
4,742 |
4,687 |
$44K |
| 58558 |
|
66 |
66 |
$43K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
222 |
209 |
$43K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,789 |
1,749 |
$41K |
| 97161 |
|
1,139 |
1,099 |
$41K |
| 72141 |
|
189 |
184 |
$40K |
| 77065 |
Tomosynthesis, mammo |
544 |
519 |
$38K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,616 |
1,480 |
$37K |
| 99173 |
|
5,625 |
5,581 |
$37K |
| 86850 |
|
4,765 |
4,522 |
$37K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
247 |
243 |
$36K |
| 96376 |
|
1,255 |
909 |
$36K |
| 86762 |
|
1,898 |
1,683 |
$36K |
| 76770 |
|
884 |
862 |
$36K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
810 |
665 |
$35K |
| 83540 |
|
4,240 |
4,080 |
$35K |
| 90715 |
|
2,917 |
2,849 |
$35K |
| 70496 |
|
264 |
255 |
$35K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,047 |
988 |
$35K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
93 |
89 |
$34K |
| 85730 |
|
5,963 |
5,521 |
$34K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,803 |
1,610 |
$34K |
| 87340 |
|
2,368 |
2,301 |
$33K |
| 76536 |
|
701 |
686 |
$33K |
| 83655 |
|
3,635 |
2,853 |
$33K |
| 86480 |
|
426 |
412 |
$33K |
| 86618 |
|
642 |
622 |
$32K |
| 87040 |
|
1,989 |
1,863 |
$31K |
| 85027 |
|
4,388 |
4,008 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17,996 |
17,108 |
$30K |
| 83690 |
|
6,718 |
6,364 |
$30K |
| H2010 |
Comprehensive medication services, per 15 minutes |
1,607 |
1,034 |
$29K |
| 87512 |
|
1,676 |
1,661 |
$29K |
| J0897 |
Injection, denosumab, 1 mg |
53 |
51 |
$28K |
| 93970 |
|
391 |
373 |
$28K |
| 71250 |
|
477 |
464 |
$28K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
481 |
320 |
$27K |
| 88142 |
|
1,608 |
1,600 |
$27K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,591 |
508 |
$27K |
| 49083 |
|
153 |
82 |
$27K |
| 70498 |
|
202 |
192 |
$25K |
| 82550 |
|
4,311 |
3,839 |
$25K |
| 84439 |
|
2,978 |
2,862 |
$24K |
| 82746 |
|
2,052 |
2,017 |
$24K |
| 82570 |
|
3,186 |
2,955 |
$23K |
| 96417 |
|
389 |
260 |
$22K |
| 87186 |
|
2,642 |
2,519 |
$22K |
| 74019 |
|
1,225 |
1,187 |
$21K |
| 72110 |
|
1,015 |
984 |
$21K |
| 87077 |
|
2,757 |
2,623 |
$20K |
| 84403 |
|
681 |
657 |
$20K |
| 64615 |
|
184 |
182 |
$20K |
| 76820 |
|
760 |
340 |
$19K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
82 |
82 |
$19K |
| 96415 |
|
584 |
455 |
$19K |
| 90686 |
|
2,907 |
2,799 |
$19K |
| 84630 |
|
1,312 |
1,298 |
$19K |
| 86901 |
|
4,765 |
4,512 |
$18K |
| 86900 |
|
4,819 |
4,562 |
$18K |
| 82565 |
|
3,478 |
3,023 |
$18K |
| 84146 |
|
675 |
652 |
$18K |
| 73564 |
|
925 |
899 |
$18K |
| 84134 |
|
891 |
845 |
$18K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
46 |
46 |
$18K |
| 83550 |
|
3,584 |
3,465 |
$17K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,470 |
8,013 |
$17K |
| 82950 |
|
2,424 |
2,382 |
$17K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
863 |
277 |
$17K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
323 |
318 |
$17K |
| 71045 |
Radiologic examination, chest; single view |
2,881 |
2,689 |
$17K |
| 84450 |
|
2,639 |
2,404 |
$16K |
| 58661 |
|
19 |
19 |
$16K |
| 87522 |
Neg quan hep c or qual rna |
396 |
381 |
$16K |
| J2785 |
Injection, regadenoson, 0.1 mg |
379 |
374 |
$16K |
| 12011 |
|
167 |
164 |
$16K |
| 83605 |
|
2,594 |
2,330 |
$16K |
| 93017 |
|
461 |
440 |
$16K |
| 84153 |
|
692 |
676 |
$16K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
352 |
340 |
$15K |
| 86140 |
|
4,538 |
4,069 |
$15K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
74 |
73 |
$15K |
| 77062 |
|
642 |
631 |
$14K |
| 73610 |
|
758 |
733 |
$14K |
| 77336 |
|
411 |
183 |
$14K |
| 83525 |
|
1,070 |
1,043 |
$14K |
| 96411 |
|
253 |
162 |
$14K |
| 76870 |
|
319 |
310 |
$14K |
| S9470 |
Nutritional counseling, dietitian visit |
430 |
423 |
$14K |
| 82043 |
|
1,579 |
1,536 |
$13K |
| 86038 |
|
796 |
776 |
$13K |
| 82803 |
|
623 |
595 |
$13K |
| 86787 |
|
616 |
436 |
$13K |
| 58300 |
|
151 |
148 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
732 |
729 |
$13K |
| 93226 |
|
346 |
342 |
$13K |
| 73030 |
|
866 |
822 |
$13K |
| 74018 |
|
925 |
875 |
$12K |
| 74178 |
|
55 |
53 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
51 |
47 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,701 |
2,579 |
$12K |
| 84145 |
|
651 |
579 |
$12K |
| 82962 |
|
6,838 |
4,950 |
$12K |
| 85379 |
|
1,335 |
1,190 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,307 |
2,159 |
$12K |
| 82784 |
|
617 |
496 |
$12K |
| 76885 |
|
116 |
114 |
$11K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
7,423 |
6,200 |
$11K |
| 83520 |
|
586 |
449 |
$11K |
| 84402 |
|
373 |
363 |
$11K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
1,111 |
1,040 |
$11K |
| 90677 |
|
1,261 |
1,250 |
$11K |
| 80076 |
|
1,217 |
1,071 |
$11K |
| 82670 |
|
487 |
462 |
$11K |
| 83516 |
|
340 |
297 |
$11K |
| 12001 |
|
209 |
202 |
$11K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
121 |
116 |
$11K |
| 73630 |
|
1,010 |
979 |
$11K |
| 62321 |
|
28 |
28 |
$10K |
| J1815 |
Injection, insulin, per 5 units |
1,749 |
1,091 |
$10K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
2,025 |
984 |
$10K |
| 44970 |
|
13 |
13 |
$10K |
| 84460 |
|
1,381 |
1,225 |
$10K |
| 80074 |
|
199 |
198 |
$10K |
| 83615 |
|
1,621 |
1,248 |
$10K |
| 84550 |
|
1,648 |
1,333 |
$10K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,816 |
1,131 |
$10K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,308 |
823 |
$10K |
| 77061 |
|
432 |
416 |
$10K |
| 84703 |
|
963 |
889 |
$10K |
| 97597 |
|
457 |
253 |
$10K |
| 86765 |
|
761 |
733 |
$10K |
| 72156 |
|
50 |
50 |
$10K |
| 83001 |
|
509 |
489 |
$10K |
| 70486 |
|
144 |
136 |
$9K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
425 |
411 |
$9K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
316 |
307 |
$9K |
| 84425 |
|
1,230 |
1,217 |
$9K |
| 84144 |
|
527 |
474 |
$9K |
| 83021 |
|
423 |
407 |
$9K |
| 85652 |
|
2,998 |
2,681 |
$9K |
| J3490 |
Unclassified drugs |
6,103 |
4,619 |
$9K |
| 0001A |
|
497 |
476 |
$9K |
| 73130 |
|
740 |
713 |
$8K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
490 |
469 |
$8K |
| 84481 |
|
333 |
317 |
$8K |
| 73502 |
|
458 |
440 |
$8K |
| 88112 |
|
282 |
249 |
$8K |
| 82947 |
|
1,969 |
1,875 |
$8K |
| 83013 |
|
117 |
116 |
$8K |
| 87081 |
|
1,270 |
1,244 |
$8K |
| 84100 |
|
1,758 |
1,350 |
$8K |
| 72070 |
|
353 |
339 |
$7K |
| 77080 |
|
125 |
121 |
$7K |
| 85018 |
|
1,940 |
1,894 |
$7K |
| 96367 |
|
657 |
529 |
$7K |
| 70491 |
|
93 |
90 |
$7K |
| 84156 |
|
1,599 |
1,409 |
$7K |
| 85384 |
|
671 |
576 |
$7K |
| 80164 |
|
378 |
331 |
$7K |
| 87902 |
|
57 |
56 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
294 |
290 |
$6K |
| 0002A |
|
324 |
314 |
$6K |
| 82330 |
|
973 |
849 |
$6K |
| 93225 |
|
348 |
344 |
$6K |
| 86706 |
|
424 |
414 |
$6K |
| 72050 |
|
225 |
220 |
$6K |
| 82652 |
|
148 |
146 |
$6K |
| 86665 |
|
228 |
120 |
$6K |
| 86696 |
|
157 |
154 |
$6K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
806 |
739 |
$6K |
| 82553 |
|
663 |
632 |
$6K |
| 88341 |
|
108 |
104 |
$6K |
| 86003 |
|
70 |
61 |
$5K |
| 84520 |
|
1,176 |
1,018 |
$5K |
| 84590 |
|
374 |
368 |
$5K |
| 83921 |
|
282 |
274 |
$5K |
| 90732 |
|
253 |
244 |
$5K |
| 97165 |
|
143 |
135 |
$5K |
| 82627 |
|
230 |
223 |
$5K |
| 82105 |
|
248 |
242 |
$5K |
| 87493 |
|
123 |
121 |
$5K |
| 87070 |
|
778 |
748 |
$5K |
| 86695 |
|
158 |
155 |
$5K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
205 |
200 |
$5K |
| 82525 |
|
351 |
346 |
$5K |
| 87252 |
|
113 |
111 |
$5K |
| 82247 |
|
660 |
537 |
$5K |
| 83002 |
|
240 |
226 |
$4K |
| 94762 |
|
93 |
89 |
$4K |
| 72052 |
|
134 |
129 |
$4K |
| 86800 |
|
210 |
208 |
$4K |
| 86431 |
|
475 |
468 |
$4K |
| 72158 |
|
37 |
37 |
$4K |
| 87205 |
|
953 |
925 |
$4K |
| 84165 |
|
326 |
311 |
$4K |
| 97166 |
|
99 |
96 |
$4K |
| 73110 |
|
356 |
348 |
$4K |
| 73590 |
|
287 |
272 |
$4K |
| 87799 |
|
304 |
153 |
$4K |
| 87147 |
|
879 |
853 |
$4K |
| 77412 |
|
119 |
14 |
$4K |
| 84446 |
|
327 |
323 |
$4K |
| 81002 |
|
1,205 |
1,066 |
$4K |
| 87899 |
|
142 |
70 |
$4K |
| 82310 |
|
512 |
501 |
$4K |
| 82378 |
|
261 |
244 |
$4K |
| 86039 |
|
222 |
216 |
$4K |
| 93350 |
|
104 |
98 |
$4K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
177 |
169 |
$4K |
| 82951 |
|
349 |
343 |
$3K |
| 72100 |
|
180 |
178 |
$3K |
| 71271 |
|
60 |
59 |
$3K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
17 |
17 |
$3K |
| C1769 |
Guide wire |
360 |
330 |
$3K |
| 93321 |
|
222 |
215 |
$3K |
| 87015 |
|
352 |
322 |
$3K |
| 94729 |
|
119 |
118 |
$3K |
| 74022 |
|
140 |
137 |
$3K |
| 82533 |
|
228 |
219 |
$3K |
| 93296 |
|
288 |
287 |
$3K |
| 93308 |
|
203 |
196 |
$3K |
| 86334 |
|
147 |
140 |
$3K |
| 83498 |
|
131 |
120 |
$3K |
| 84132 |
|
747 |
705 |
$3K |
| 58301 |
|
30 |
30 |
$3K |
| 81511 |
|
29 |
29 |
$3K |
| 86235 |
|
57 |
55 |
$3K |
| 85014 |
|
1,074 |
1,007 |
$3K |
| 73562 |
|
185 |
180 |
$3K |
| G0498 |
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion |
22 |
14 |
$3K |
| 83721 |
|
267 |
263 |
$3K |
| 80051 |
|
519 |
438 |
$3K |
| 10060 |
|
60 |
56 |
$3K |
| 86617 |
|
67 |
62 |
$3K |
| 87253 |
|
85 |
84 |
$3K |
| 78264 |
|
28 |
28 |
$3K |
| 86664 |
|
132 |
120 |
$3K |
| 86376 |
|
297 |
289 |
$3K |
| 82800 |
|
296 |
282 |
$3K |
| 82977 |
|
263 |
215 |
$2K |
| 73080 |
|
235 |
227 |
$2K |
| 84295 |
|
578 |
554 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
4,989 |
4,236 |
$2K |
| 99001 |
|
248 |
242 |
$2K |
| H0034 |
Medication training and support, per 15 minutes |
108 |
83 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17,722 |
15,869 |
$2K |
| 95816 |
|
186 |
181 |
$2K |
| 84436 |
|
231 |
225 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
23,682 |
12,537 |
$2K |
| 94726 |
|
87 |
87 |
$2K |
| 86255 |
|
121 |
115 |
$2K |
| 86663 |
|
131 |
120 |
$2K |
| 84480 |
|
248 |
237 |
$2K |
| 73090 |
|
199 |
193 |
$2K |
| J0185 |
Injection, aprepitant, 1 mg |
39 |
24 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,056 |
3,391 |
$2K |
| 73552 |
|
132 |
129 |
$2K |
| 90474 |
|
201 |
201 |
$2K |
| 90621 |
|
45 |
42 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
14 |
14 |
$2K |
| 86769 |
|
164 |
155 |
$2K |
| 73700 |
|
40 |
38 |
$2K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,275 |
1,236 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
270 |
206 |
$2K |
| 77334 |
|
50 |
40 |
$2K |
| 73560 |
|
153 |
147 |
$2K |
| 90750 |
|
58 |
55 |
$2K |
| 87045 |
|
265 |
255 |
$2K |
| 88304 |
|
335 |
322 |
$2K |
| Q0114 |
Fern test |
173 |
167 |
$2K |
| 82040 |
|
472 |
445 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,670 |
1,986 |
$2K |
| 90682 |
|
369 |
360 |
$2K |
| 96040 |
|
29 |
25 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,266 |
1,138 |
$2K |
| 96401 |
|
102 |
64 |
$2K |
| 86708 |
|
103 |
101 |
$2K |
| 70360 |
|
155 |
153 |
$2K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
36 |
32 |
$2K |
| 88307 |
|
198 |
192 |
$2K |
| 72040 |
|
97 |
96 |
$2K |
| 86481 |
|
26 |
26 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
64 |
26 |
$2K |
| 73140 |
|
170 |
169 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
468 |
369 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,279 |
6,665 |
$1K |
| 76882 |
|
202 |
182 |
$1K |
| 96160 |
|
2,677 |
2,662 |
$1K |
| 76801 |
|
30 |
29 |
$1K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
158 |
149 |
$1K |
| 82010 |
|
344 |
325 |
$1K |
| 85045 |
|
290 |
269 |
$1K |
| 87625 |
|
39 |
39 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,900 |
2,290 |
$1K |
| 11043 |
|
29 |
25 |
$1K |
| 11982 |
|
12 |
12 |
$1K |
| 72170 |
|
129 |
126 |
$1K |
| 88346 |
|
79 |
73 |
$1K |
| 86704 |
|
80 |
78 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
7,154 |
5,495 |
$1K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
18 |
12 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
27 |
27 |
$1K |
| 90633 |
|
136 |
135 |
$1K |
| 93880 |
|
26 |
25 |
$1K |
| 72081 |
|
47 |
47 |
$1K |
| 86160 |
|
34 |
31 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,594 |
2,086 |
$1K |
| 87272 |
|
54 |
53 |
$978.63 |
| 73060 |
|
98 |
91 |
$961.20 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,173 |
4,201 |
$931.49 |
| 59025 |
Fetal non-stress test |
176 |
80 |
$929.83 |
| 84160 |
|
137 |
132 |
$922.07 |
| 87046 |
|
269 |
257 |
$914.57 |
| 80178 |
|
117 |
98 |
$903.42 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
536 |
406 |
$894.79 |
| 90656 |
|
272 |
270 |
$884.98 |
| 96368 |
|
120 |
88 |
$877.66 |
| 90670 |
|
43 |
38 |
$845.78 |
| 99152 |
|
239 |
226 |
$825.50 |
| 90744 |
|
209 |
203 |
$825.39 |
| 76825 |
|
41 |
38 |
$761.47 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,826 |
2,085 |
$757.84 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
21 |
12 |
$755.44 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,731 |
11,909 |
$750.81 |
| 80197 |
|
76 |
55 |
$738.39 |
| 87269 |
|
54 |
53 |
$733.67 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,844 |
908 |
$726.94 |
| 86225 |
|
42 |
42 |
$699.25 |
| 87088 |
|
84 |
78 |
$681.31 |
| 97163 |
|
13 |
13 |
$671.90 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,089 |
1,015 |
$661.56 |
| 86645 |
|
29 |
26 |
$650.92 |
| 84466 |
|
40 |
40 |
$647.31 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,611 |
1,227 |
$611.01 |
| 12002 |
|
14 |
14 |
$607.31 |
| 72131 |
|
15 |
14 |
$600.60 |
| J2060 |
Injection, lorazepam, 2 mg |
3,028 |
2,395 |
$598.76 |
| 86308 |
|
76 |
74 |
$598.70 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,716 |
2,474 |
$593.07 |
| 85007 |
|
127 |
125 |
$581.90 |
| 99406 |
|
204 |
199 |
$577.72 |
| 85460 |
|
57 |
50 |
$572.45 |
| 93325 |
|
15 |
14 |
$536.72 |
| 90734 |
|
132 |
128 |
$516.20 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,356 |
2,047 |
$510.75 |
| 83930 |
|
225 |
213 |
$497.35 |
| 87517 |
|
13 |
12 |
$493.74 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
65 |
65 |
$477.92 |
| 99153 |
Mod sedat endo service >5yrs |
253 |
240 |
$466.31 |
| 82785 |
|
31 |
30 |
$435.42 |
| 96523 |
|
28 |
26 |
$397.28 |
| 80177 |
|
35 |
33 |
$392.87 |
| 84305 |
|
14 |
13 |
$379.24 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
61 |
61 |
$377.74 |
| 73522 |
|
17 |
17 |
$371.23 |
| 84155 |
|
111 |
105 |
$368.72 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,163 |
1,725 |
$367.96 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
288 |
197 |
$361.80 |
| 86592 |
|
85 |
82 |
$356.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
25 |
14 |
$347.90 |
| 94760 |
|
225 |
211 |
$343.88 |
| 83010 |
|
27 |
26 |
$342.12 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,050 |
1,023 |
$340.19 |
| 94681 |
|
15 |
15 |
$338.93 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,261 |
864 |
$331.39 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
52 |
51 |
$320.71 |
| 82140 |
|
89 |
80 |
$312.68 |
| 95819 |
|
26 |
26 |
$310.29 |
| 87102 |
|
32 |
32 |
$298.05 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,466 |
5,098 |
$297.76 |
| 82390 |
|
26 |
26 |
$293.84 |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,145 |
1,151 |
$293.59 |
| 87641 |
|
13 |
12 |
$277.92 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,467 |
2,514 |
$274.12 |
| G0010 |
Administration of hepatitis b vaccine |
69 |
66 |
$266.30 |
| 0071A |
|
493 |
491 |
$265.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
1,512 |
1,198 |
$264.48 |
| 80069 |
|
47 |
38 |
$260.34 |
| 94010 |
|
42 |
41 |
$259.50 |
| 86580 |
|
47 |
45 |
$258.12 |
| 86644 |
|
13 |
12 |
$257.19 |
| 85041 |
|
75 |
69 |
$256.70 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
544 |
498 |
$244.11 |
| 87209 |
|
13 |
12 |
$235.25 |
| 82103 |
|
12 |
12 |
$228.65 |
| 94060 |
|
24 |
24 |
$218.67 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
1,896 |
1,703 |
$217.59 |
| 43775 |
|
12 |
12 |
$211.72 |
| 82150 |
|
40 |
40 |
$210.20 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
644 |
592 |
$181.36 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
100 |
64 |
$179.34 |
| 96402 |
|
15 |
12 |
$166.72 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
294 |
285 |
$161.51 |
| 81050 |
|
31 |
31 |
$160.29 |
| OP250 |
|
90 |
39 |
$140.66 |
| J1953 |
Injection, levetiracetam, 10 mg |
18 |
14 |
$135.12 |
| 74220 |
|
12 |
12 |
$133.69 |
| 0072A |
|
464 |
463 |
$132.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
253 |
153 |
$102.62 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,078 |
2,754 |
$99.82 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
8,256 |
6,300 |
$99.37 |
| 88302 |
|
31 |
31 |
$93.95 |
| 87075 |
|
13 |
12 |
$91.60 |
| 87177 |
|
13 |
12 |
$87.85 |
| 73660 |
|
14 |
14 |
$76.59 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
39 |
26 |
$72.29 |
| 77001 |
|
16 |
14 |
$56.83 |
| 0003A |
|
12 |
12 |
$44.00 |
| 96161 |
|
4,263 |
3,931 |
$42.61 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
334 |
224 |
$41.25 |
| 85651 |
|
15 |
14 |
$40.65 |
| 96127 |
|
1,845 |
1,836 |
$29.68 |
| J3411 |
Injection, thiamine hcl, 100 mg |
14 |
14 |
$18.39 |
| 99441 |
|
14 |
14 |
$18.00 |
| 88300 |
|
26 |
25 |
$16.29 |
| J7510 |
Prednisolone oral, per 5 mg |
32 |
30 |
$15.15 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
716 |
517 |
$14.16 |
| J1940 |
Injection, furosemide, up to 20 mg |
21 |
13 |
$8.38 |
| 99205 |
Prolong outpt/office vis |
25 |
25 |
$0.01 |
| J1756 |
Injection, iron sucrose, 1 mg |
807 |
378 |
$0.00 |
| 0124A |
|
188 |
188 |
$0.00 |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
706 |
563 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
172 |
154 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
592 |
584 |
$0.00 |
| J2323 |
Injection, natalizumab, 1 mg |
42 |
39 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
24 |
24 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
232 |
187 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
268 |
252 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
696 |
685 |
$0.00 |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
14 |
13 |
$0.00 |
| 91320 |
|
201 |
197 |
$0.00 |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
23 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
90 |
66 |
$0.00 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
14 |
12 |
$0.00 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
13 |
12 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
23 |
12 |
$0.00 |
| J7606 |
Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms |
73 |
31 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
13 |
13 |
$0.00 |
| 3046F |
|
38 |
36 |
$0.00 |
| 90619 |
|
140 |
136 |
$0.00 |
| 90673 |
|
21 |
21 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
27 |
27 |
$0.00 |
| 0051A |
|
523 |
522 |
$0.00 |
| 90480 |
|
140 |
129 |
$0.00 |
| 90375 |
|
26 |
25 |
$0.00 |
| 00000 |
|
9,376 |
2,950 |
$0.00 |
| 90698 |
|
229 |
223 |
$0.00 |
| A9150 |
Non-prescription drugs |
101 |
78 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
327 |
279 |
$0.00 |
| 0082A |
|
12 |
12 |
$0.00 |
| 3044F |
|
14 |
13 |
$0.00 |
| 0052A |
|
47 |
47 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
26 |
24 |
$0.00 |